Approaches to efficient production of recombinant angiogenesis inhibitor rhVEGI-192 and characterization of its structure and antiangiogenic function

Methods to prepare pure, bioactive recombinant human vascular endothelial growth inhibitor (rhVEGI), a potent inhibitor of angiogenesis potentially applicable in antiangiogenic cancer therapy, are in urgent demand for preclinical investigation as well as future clinical trials of the protein. Here,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Xu, Wu, Jueheng, Liu, Hanning, He, Zhenjian, Gu, Minghui, Wang, Ning, Ma, Jianda, Hu, Jieping, Xia, Lei, He, Haipeng, Yuan, Jie, Li, Jun, Li, Luyuan, Li, Mengfeng, Zhu, Xun
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Subscription Services, Inc., A Wiley Company 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2866271/
https://ncbi.nlm.nih.gov/pubmed/20052682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pro.323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados